În afara temei aiqbench
Această știre a fost preluată de la o sursă pe care o urmărim, dar nu ține de domeniul AI sau cuantic, așa că nu există o perspectivă aiqbench pentru ea.
Psychedelic medicine is approaching a turning point. The U.S. needs the right infrastructure to be ready
Today’s psychedelics bear little resemblance to 1970s counterparts. These medicines undergo rigorous clinical trials and licensed manufacturing processes.
On September 14, the FDA set aside four hours and invited more than 80 speakers to consider how psychedelic therapies might work in regulated settings. The discussion reflected growing interest from regulators, physicians, patients, and veterans’ organizations in how these potential treatments may offer relief to those living with mental illness. But it also revealed a gap beyond rescheduling or reclassification: the infrastructure needed to deliver these…
Extras afișat conform termenilor RSS ai publicației · 67 cuvinte · textul integral și figurile sunt pe site-ul publicației
Subiecte conexe
BRICS Draws a New Global Line: Full Text of New Delhi Declaration
slguardian.org · 12 sept. 2026
Why so many therapy etc. frameworks think they're The One True Approach
LessWrong · 1 aug. 2026
Amazon Research Awards recipients announced
Amazon Science · 27 mai 2026
Tariffs didn’t bring manufacturing jobs back to the US
The Verge · 27 iul. 2026